EAEAX
Price
$42.80
Change
+$0.33 (+0.78%)
Updated
Jul 31 closing price
Net Assets
926.06M
RGWBX
Price
$29.76
Change
+$0.31 (+1.05%)
Updated
Jul 31 closing price
Net Assets
28.22B
Interact to see
Advertisement

EAEAX vs RGWBX

EAEAX vs RGWBX Comparison Chart in %
View a ticker or compare two or three
VS
EAEAX vs. RGWBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAEAX is a Buy and RGWBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGWBX has more cash in the bank: 28.2B vs. EAEAX (926M). EAEAX pays higher dividends than RGWBX: EAEAX (0.38) vs RGWBX (0.00). EAEAX was incepted earlier than RGWBX: EAEAX (24 years) vs RGWBX (14 years). EAEAX (1.73) is less costly to investors than RGWBX (1.46). EAEAX is a more actively managed with annual turnover of: 10.00 vs. RGWBX (1.00). RGWBX has a lower initial minimum investment than EAEAX: RGWBX (250) vs EAEAX (1000). EAEAX annual gain was more profitable for investors over the last year : 13.39 vs. RGWBX (10.02). EAEAX return over 5 years is better than : 41.95 vs. RGWBX (16.76).
EAEAXRGWBXEAEAX / RGWBX
Total Expense Ratio1.201.4682%
Annual Report Gross Expense Ratio1.731.46118%
Fund Existence24 years14 years-
Gain YTD10.7957.983135%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets926M28.2B3%
Annual Yield % from dividends0.380.00-
Returns for 1 year13.3910.02134%
Returns for 3 years46.2544.59104%
Returns for 5 years41.9516.76250%
Returns for 10 years157.3999.90158%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LMUB49.66-0.05
-0.10%
iShares Long-Term National Muni Bd ETF
MIG20.92-0.06
-0.27%
VanEck IG Corporate ETF
HOLA56.05-0.20
-0.36%
JPMorgan Intl Hdg Eq Ldrd Overlay ETF
BTZ9.97-0.05
-0.50%
BlackRock Credit Allocation Income Trust
IDNA32.33-0.46
-1.40%
iShares Genomics Immnlgy & Hlthcr ETF